The present invention provides methods of providing a prognosis for a lung cancer in a subject and methods of predicting the risk of metastasis of a lung cancer in a subject. The present invention additionally provides kits that find use in the practice of the methods of the invention....
8. Amila Suraweera, Alex Duff, Mark N Adams. et al. Defining COMMD4 as an anti-cancer therapeutic target and prognostic factor in non-small cell lung cancer. Br J Cancer. 2020 May 22. Online ahead of print. ...
大型肝癌早筛临床研究(DECIPHER-Liver)成果发表于Hepatology(IF=17.3);2022年6月,国内首个大型泛癌种早筛研究(DECIPHER-Multi)成果发表于Mol Cancer(IF=41.4);2022年6月,国内首个基于cfDNA Motif特征的肺癌早筛大型临床研究(DECIPHER-Lung)成...
E., David, P. et al.Pathologic complete response to preoperative chemotherapy predicts cure in early-stage non-small-cell lung cancer: combined analysis of two IFCT randomized trials. J Thorac. Oncol. 7, 841–849 (2012).
Role of CPS1in Cell Growth, Metabolism and Prognosis in LKB1-Inactivated LungAdenocarcinoma 研究背景 肝激酶B(Liver kinase, LKB1)是一种丝氨酸/苏氨酸蛋白激酶,目前公认的抑癌因子,但LKB1的失活突变会促进肿瘤的转移和侵袭,且LKB1失活会导致肺癌临床治疗预后效果变差。氨甲酰磷酸合成酶1(CPS1)是尿素代谢循环中...
This Review summarizes the successes and challenges of using different types of molecule as biomarkers, using lung cancer as a key illustrative example. Efforts at the national level of several countries to tie molecular measurement of samples to patient data via electronic medical records are the ...
This Review summarizes the successes and challenges of using different types of molecule as biomarkers, using lung cancer as a key illustrative example. Efforts at the national level of several countries to tie molecular measurement of samples to patient data via electronic medical records are the ...
[1] Pabst L, Lopes S, Bertrand B, Creusot Q, Kotovskaya M, Pencreach E, Beau-Faller M, Mascaux C. Prognostic and Predictive Biomarkers in the Era of Immunotherapy for Lung Cancer. Int J Mol Sci. 2023 Apr 20;24(8):7577.
Moutafi MK, Molero M, Martinez Morilla S, et al. Spatially resolved proteomic profiling identifies tumor cell CD44 as a biomarker associated with sensitivity to PD-1 axis blockade in advanced non-small-cell lung cancer. Journal for ImmunoTherapy of Cancer 2022;10:e004757. doi:10.1136/jitc-2022...
[1]Mathé EA, Patterson AD, Haznadar M, et al. Noninvasive urinary metabolomic profiling identifies diagnostic and prognostic markers in lung cancer.Cancer Res. 2014;74(12):3259-3270. doi:10.1158/0008-5472.CAN-14-0109. [2]Qiang Huang, Yexi...